Advisory panel unanimously recommends FDA authorize Johnson & Johnson COVID-19 vaccine

A lab worker holds a vial of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine candidate in an undated photograph. Johnson & Johnson/Handout via REUTERS.

WASHINGTON: A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted in favor of authorizing Johnson & Johnson's one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.

The FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires a single shot.